Breast cancer highlights from ASCO 2019
Dr Matteo Lambertini speaks with ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the conference highlights in breast cancer research.
He first discusses results from two studies in the metastatic HER2-positive setting, the SOPHIA trial and the NALA trial, before going on to discuss two studies in hormone receptor positive metastatic breast cancer, the MONALEESA-7 trial and a Korean trial investigating whether it's better to start with chemotherapy or endocrine therapy.
Dr Lambertini then reports findings from an international, retrospective study that he presented on the safety of pregnancy following breast cancer in patients with a. BRCA mutation.
He concludes by discussing the GeparOLA tand the GIM4 trials.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
Видео Breast cancer highlights from ASCO 2019 канала ecancer
He first discusses results from two studies in the metastatic HER2-positive setting, the SOPHIA trial and the NALA trial, before going on to discuss two studies in hormone receptor positive metastatic breast cancer, the MONALEESA-7 trial and a Korean trial investigating whether it's better to start with chemotherapy or endocrine therapy.
Dr Lambertini then reports findings from an international, retrospective study that he presented on the safety of pregnancy following breast cancer in patients with a. BRCA mutation.
He concludes by discussing the GeparOLA tand the GIM4 trials.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
Видео Breast cancer highlights from ASCO 2019 канала ecancer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC
Breast cancer prevention in high-risk post-menopausal women
Regional lymph node irradiation in early breast cancer
Latest advances in mHSPC from ASCO GU 2020
ESMO 2017: Prostate cancer highlights
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans
The CAR T cell revolution in cancer therapy
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients
CLL14: Venetoclax plus obinutuzumab in untreated CLL
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...
Managing the side effects of CAR T-cell therapy
LUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Advances in prostate cancer in the last 10 years and a glimpse to the future
Holistic management of patients with ALK-positive NSCLC
Master pathways and targets in T cell acute lymphoblastic leukaemia
Elacestrant significantly prolongs PFS for ER+/HER2- metastatic BC without prior chemotherapy pts
The role of lymph nodes in stage 3 lung cancer
Stereotactic body radiotherapy compared with surgery for localised prostate cancer